0001127602-24-010489.txt : 20240318 0001127602-24-010489.hdr.sgml : 20240318 20240318173431 ACCESSION NUMBER: 0001127602-24-010489 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240314 FILED AS OF DATE: 20240318 DATE AS OF CHANGE: 20240318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CHAOUKI STEVEN M CENTRAL INDEX KEY: 0001776865 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41455 FILM NUMBER: 24760261 MAIL ADDRESS: STREET 1: C/O TRANSUNION, 555 WEST ADAMS STREET CITY: CHICAGO STATE: IL ZIP: 60661 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAIA Biotechnology, Inc. CENTRAL INDEX KEY: 0001878313 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 312-416-8592 MAIL ADDRESS: STREET 1: 444 WEST LAKE STREET, SUITE 1700 CITY: CHICAGO STATE: IL ZIP: 60606 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-03-14 0001878313 MAIA Biotechnology, Inc. MAIA 0001776865 CHAOUKI STEVEN M 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 1 0 Common Stock 2024-03-14 4 P 0 34641 1.17 A 88891 D Warrants 1.30 2024-03-14 4 P 0 34641 1.30 A 2024-09-14 2029-09-14 Common Stock 34641 34641 D The warrants were purchased pursuant to a Securities Purchase Agreement dated March 11, 2024 and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on March 14, 2024. The options are exercisable beginning on the six month anniverary of the issuance date and expire 5-years after the initial exercise date. /s/ Steven M. Chaouki 2024-03-18